Technology
With the help of artificial intelligence and the Internet of Things, we have been able to calculate physiological values such as blood glucose, glycosylated hemoglobin, blood pressure, and heart rate from ECG electrocardiograms, providing people with comprehensive health management solutions, especially for patients with type 2 diabetes. In 2006, Revlis took the initiative to participate in overseas research projects and discovered the relationship between type 2 diabetes and autonomic nervous dysfunction, so we quickly launched the technical development of non-invasive blood glucose measurement.
The ECG technology uses sensors to receive the human body's electrical signals. When the heart beats, the potential changes generated can show the waveforms of heart rate (heartbeat rate) and heart rhythm (heartbeat rhythm) in ECG, which is the so-called PQRST waveform. The heart rate is based on the spontaneous signal of the heart's sinoatrial node, and combined with the autonomic nerve to control the speed of the heart rate.
The principle of non-invasive blood glucose technology is based on the fact that the blood glucose of healthy people rises after eating, thus speeding up the heart rate. By combining the blood glucose concentration with the effect of the glucose utilization of myocardial cells on the heart, different blood glucose conditions can be further deduced by heart rate variability (HRV) and electrocardiogram.
Therefore, physiological parameters such as blood glucose, glycosylated hemoglobin, blood pressure and heart rate can be calculated through AI technology. When the sensor receives the ECG signal, it will send this signal to artificial intelligence machine learning for calculation. With the addition of Revlis’ vast database of records, machine learning will continue to progress, presenting a personalized and interactive technology application.
Terms and Conditions
When you visit, browse or use “www.revlis-ai.com”(hereinafter referred to as this website), you acknowledge that you have read, understood and agreed to the Terms and Conditions announced by Revlis Biotech Company Limited (hereinafter referred to as the company), and agree to abide by the relevant laws and regulations of the company's location.
1. User statement
(1) When you visit, browse or use this website, you do not need to provide
personal information or become a member, and no fees to be paid.
(2) When you consult the company's related business through the message
function of this website, you may need to leave personal information for
contact, and the personal information you provide will be protected and
regulated by the company's privacy policy.
(3) Users shall abide by the rules and practices of this website. When using this
website and other related websites of the company, it is prohibited to:
A. Invade any system on the network
B. Destroy the network system and various services
C. Retrieve, use, and publish resources that are not officially opened or
authorized by the owner
D. Engaging in acts that violate public order, good customs, and prohibited
by law
E. Engage in illegal trading or post false or criminal information
F. Engage in acts involving defamation, intimidation and any unlawful
infringement of the rights of others
G. Transmission or distribution of computer viruses
2. IP Protection
The intellectual property rights of all text, company names, data, windows, videos, pictures, photos and data in this website and other related websites of the company are owned by the company and other rights holders. You shall not change any information/data and without the written permission of our company, you are not allowed to copy, distribute, reprint, display, play, hyperlink or store the materials on this website and related websites in any way in the information retrieval system.
The trademarks and service marks used and displayed on this website and other related websites of the company are registered and unregistered trademarks of the company and other rights holders. You shall not use the above trademarks or marks in any way without the written permission of the company or other rights holders. The information/data disclosed on this website and related websites does not mean that the company grants you any license of copyright, patent or other intellectual property rights.
3. Restrictive guarantee
Any information/data contained in this website and other related websites of the company, including but not limited to text, graphics, etc., can be modified or updated by the company and other rights holders without notice, and will be taken as "existing status”. The company does not guarantee the accuracy, reliability or completeness of this information/data, and does not provide any express/implied or statutory representations and guarantees, including but not limited to non-infringement, ownership, specific use, no computer virus and other guarantees.
4. Disclaimer
In any case, the company shall not be liable for any direct, indirect, special or consequential losses caused by the use of this website and other related websites of the company or the connection to other websites, including but not limited to any loss of profit, business interruption, information/data loss, etc.
5. Content revision
The company can revise the terms of this statement at any time by updating announcements or other public methods. You can visit or browse this website and other related websites of the company regularly to confirm and accept the current terms and conditions. We will also update the content of this website from time to time, the functions will increase/decrease, and the icons may be slightly different.
6. Contact Us
Revlis Biotech Company Limited.
Address: 7F., No.108-1, Minquan Rd., Xindian Dist., New Taipei City 231, Taiwan (R.O.C.)
Office: +886-2-22198878
Email: cmate.health@revlis.com.tw